= RXV
:render_as: Level3
:v291_section: 4A.4.8

The RXV segment details the pharmacy or treatment application’s encoding of specific infusion order parameters

HL7 Attribute Table – RXV – Pharmacy/Treatment Infusion

[width="100%",cols="14%,6%,7%,6%,6%,6%,7%,7%,41%",options="header",]

|===

|SEQ |LEN |C.LEN |DT |OPT |RP/# |TBL# |ITEM # |ELEMENT NAME

|1 | | |SI |O | | |03318 |Set ID - RXV

|2 |1..1 | |ID |R | |file:///E:\V2\v2.9%20final%20Nov%20from%20Frank\V29_CH02C_Tables.docx#HL70917[0917] |03319 |Bolus Type

|3 | | |NM |O | | |03320 |Bolus Dose Amount

|4 | | |CWE |O | |0767 |03321 |Bolus Dose Amount Units

|5 | |20= |NM |O | | |03322 |Bolus Dose Volume

|6 | | |CWE |O | |0768 |03323 |Bolus Dose Volume Units

|7 |1..2 | |ID |R | |file:///E:\V2\v2.9%20final%20Nov%20from%20Frank\V29_CH02C_Tables.docx#HL70918[0918] |03324 |PCA Type

|8 | |20= |NM |O | | |03325 |PCA Dose Amount

|9 | | |CWE |O | |0769 |03326 |PCA Dose Amount Units

|10 | |20= |NM |O | | |03327 |PCA Dose Amount Volume

|11 | | |CWE |O | |0770 |03328 |PCA Dose Amount Volume Units

|12 | |20= |NM |O | | |03329 |Max Dose Amount

|13 | | |CWE |O | |0772 |03330 |Max Dose Amount Units

|14 | |20= |NM |O | | |03331 |Max Dose Amount Volume

|15 | | |CWE |O | |0773 |03332 |Max Dose Amount Volume Units

|16 | | |CQ |R | | |03333 |Max Dose per Time

|17 | | |CQ |O | | |03334 |Lockout Interval

|18 | | |CWE |O | | |03339 |Syringe Manufacturer

|19 | | |CWE |O | | |03385 |Syringe Model Number

|20 | |20= |NM |C | | |03386 |Syringe Size

|21 | | |CWE |C | | |03431 |Syringe Size Units

|22 |1..1 | |ID |O | |file:///E:\V2\v2.9%20final%20Nov%20from%20Frank\V29_CH02C_Tables.docx#HL70206[0206] |00816 |Action Code

|===

